Top 50 Pharma Tracker: eHCPs share pharma sponsored webinar, nurse guidelines and recent approvals

01.02.2024 | Tracker

Top 50 Pharma Tracker: eHCPs share pharma sponsored webinar, nurse guidelines and recent approvals

Discover what healthcare professionals (eHCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are eHCPs responding to drug launch news? How are eHCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of eHCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by eHCPs on X

January
Rank
December
Rank
Company
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer3,4582710
22Moderna1,9421290
33Johnson & Johnson5451721
45AstraZeneca4181665
54GSK366889
66Novavax294220
711Bayer281943
87BioNTech23080
916Lilly214990
1012Roche212726
1113Novo Nordisk2101144
128Merck & Co1791136
1310Sanofi1748112
1415Novartis169942
1420AbbVie1691502
1642Grifols16420
1721Abbott1511473
189Gilead Sciences129531
1929Takeda1141040
2025Organon6100
2124Servier5985
2217BMS58500
2323Boehringer Ingelheim48402
2419Vertex44444
2527Regeneron43200
2518Amgen39192
2733Biogen36150
2822Otsuka3210
2825Fresenius32260
3037Eisai2071
3114Astellas19130
3127Daiichi Sankyo19146
3339Viatris1510
3431Merck KGaA1373
3539UCB12125
3632Ipsen870
3730Menarini710
3733Bausch731
3943Teva664
4036Sun520
4037CSL530
4250Incyte430
4335Jazz Pharmaceuticals300
4441Chugai211
4550Horizon110
5044CSPC000
5044Shanghai000
5050Perrigo000
5050Sino000
5050Jiangsu Hengrui000

The latest insights from eHCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by eHCPs on X in January 2024 were Pfizer, Moderna, Johnson & Johnson, GSK and AstraZeneca.

CREATION.co identified 8,494 eHCP mentions of pharmaceutical companies in January 2024, decreasing by 18% over the previous month.

On 16 January, cardiologist Pradeep Natarajan celebrated Vertex Pharmaceuticals’ “big news” for receiving FDA expanded-approval of Casgevy. The CRISPR-based therapy received approval for treating transfusion-dependent beta thalassaemia. 

On the same day in Hong Kong, oncologist Erika Hamilton shared a post from her “fantastic time” spent with AstraZeneca and Daiichi Sankyo discussing treatments and therapies for HER2low breast cancer.

And on 29 January, eHCPs shared a link to register for a webinar for empowering women surgeons. The webinar was developed in collaboration with Johnson & Johnson MedTech, with the goal of considering the challenges, dynamics and advantages faced. The webinar registration link was shared by 13 eHCPs.

The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:

  1. A handbook for nurses and HCPs for administration of IV medication.
  2. A webinar for “Empowering Women Surgeons”, in collaboration with Johnson & Johnson Innovative Medicine.
  3. An article discussing Novavax’s COVID-19 vaccine protection.

CREATION.co continues to analyse online eHCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

 

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

 

Methodology notes:

    • In January 2024, CREATION Pinpoint® identified 8,494 healthcare professional authored posts on X (Twitter) from 3,405 individual eHCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
    • Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 31 January 2024.
  • Unless otherwise specified, mentions of a company are not limited to its X account(s).
  • In some cases, an X post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In January 2024, 41 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.

Share this article

Meet the Author

Aman Jandu

With a background working in IT systems administration, and leveraging a 1st Class degree in Digital Technologies, Aman uses his technical skills to apply a systematic approach to gather data and analyse insights.

Aman loves to Speedcube. While he can currently solve a Rubik’s Cube in around 20 seconds, he is learning how to complete it blindfolded.

Suggested next


#PancChat continues to drive HCP conversation online

16.08.2019 | Article

#PancChat continues to drive HCP conversation online

#PancChat continues to drive HCP conversation online

By Lara Meyer

We’re studying what healthcare professionals think about pancreatic cancer treatment: here’s why

17.04.2019 | Article

We’re studying what healthcare professionals think about pancreatic cancer treatment: here’s why

We’re studying what healthcare professionals think about pancreatic cancer treatment: here’s

By Laura McIntyre

View all articles >